| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |